The effect of positional realignment on dose delivery to the prostate and organs-at-risk for 3DCRT

被引:19
|
作者
Wang, Zhou [1 ]
Rajagopalan, Balu [1 ]
Malhotra, Harish K. [1 ]
Kuettel, Michael R. [1 ]
Podgorsak, Matthew B. [1 ]
机构
[1] Roswell Pk Canc Inst, Dept Radiat Med, Buffalo, NY 14263 USA
关键词
prostate carcinoma; organ motion; ultrasound guidance; 3D conformal radiotherapy; BEAM RADIATION-THERAPY; RADIOTHERAPY; CANCER; MOTION; MARKERS; DISTRIBUTIONS; LOCALIZATION; CARCINOMA;
D O I
10.1016/j.meddos.2006.08.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, we evaluate the impact of daily image-guided patient repositioning on dose delivery to prostate and sensitive organs in the treatment of prostate carcinoma with 3-dimensional conformal radiation therapy (3DCRT). Five patients with substantial ultrasound-documented interfractional prostate motion during their 3DCRT treatment course were selected. Starting with the original treatment plan, 2 additional plans were retrospectively generated for each patient. In one set, organ contours were moved for each fraction, thus simulating positioning with misalignment caused by organ motion if ultrasound guidance were not used. In a second set of plans, the isocenter was shifted, as were the organ contours, simulating realignment based on the ultrasound image. In all cases, the number of planned monitor units was set to those of the original plan. For a given patient, isodose distributions, dose-volume histograms (DVHs), equivalent uniform dose (EUD) for prostate, and generalized equivalent uniform dose (gEUDs) for bladder and rectum were calculated for each fraction and then combined for each shift condition. In all reconstructed plans, the results show no substantial changes in dose coverage of the prostate (< 0.21 % change in EUD) compared to the original plan. However, in some cases with no realignment, a larger volume of the bladder or rectum gets higher dose, with the consequent gEUD for each organ significantly greater compared to the original plan. (C) 2007 American Association of Medical Dosimetrists.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [41] Daily Organs-At-Risk Variations and Their Impact on Dose Target Coverage in Pancreatic Tumors
    Rinzema, Myrian
    Palacios, Miguel A.
    Bohoudi, Omar
    Versteijne, Eva
    Bruynzeel, Anna M. E.
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S5992 - S5994
  • [42] A method to dynamically balance intensity modulated radiotherapy dose between organs-at-risk
    Das, Shiva K.
    MEDICAL PHYSICS, 2009, 36 (05) : 1744 - 1752
  • [43] Effect of using bolus on the efficiency of the 3DCRT of the breast cancer after mastectomy
    Hassan, Iman Ghali
    Naji, Nabaa Rasheed
    Abdullah, Hadeel Kamil
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2024, 74 (10) : S336 - S339
  • [44] Conformal radiotherapy of prostate cancer: What is the proper technique for sparing organs-at-risk?
    Peppa, V.
    Mazonakis, M.
    Kachris, S.
    Varveris, C.
    Damilakis, J.
    ONCOLOGY REPORTS, 2010, 23 (06) : 1663 - 1668
  • [45] HYPOFRACTIONATED VS. CONVENTIONALLY FRACTIONATED 3DCRT FOR HIGH-RISK PROSTATE CANCER: UPDATED RESULTS OF A RANDOMIZED TRIAL
    Giordano, Carolina
    Ferraro, Anna Maria
    Saracino, Biancamaria
    Petrongari, Maria Grazia
    Arcangeli, Giorgio
    Landoni, Valeria
    Arcangeli, Stefano
    Strigari, Lidia
    Gomellini, Sara
    Arcidiacono, Fabio
    Sanguineti, Giuseppe
    ANTICANCER RESEARCH, 2015, 35 (06) : 3636 - 3637
  • [46] A Method to Evaluate Dosimetric Effects On Organs-At-Risk for Treatment Delivery Systematic Uncertainties
    Liu, S.
    Mazur, T.
    Fu, Y.
    Li, H.
    Mutic, S.
    Yang, D.
    MEDICAL PHYSICS, 2017, 44 (06) : 3296 - 3296
  • [47] Late rectal bleeding in prostate cancer high-dose 3DCRT: Testing the predictive power of best fitted NTCP parameters
    Rancati, T.
    Fellin, G.
    Fiorino, C.
    Valdagni, R.
    Bianchi, C.
    Menegotti, L.
    Baccolini, M.
    Pasquino, M.
    Mapelli, M.
    Vavassori, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S337 - S337
  • [48] Modelling rectal toxicity in 3DCRT of prostate cancer: results from the Italian multicentric study
    Fiorino, C
    Rancati, T
    Gagliardi, G
    Cattaneo, GM
    Fellin, G
    Sanguineti, G
    Vavassori, V
    Valdagni, R
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S189 - S189
  • [49] ACUTE TOXICITY IN HYPOFRACTIONATED RADIOTHERAPY OF PROSTATE CANCER: VMAT VERSUS 3DCRT WITH DAILY IGRT
    Grimaldi, Gianmarco
    Vittorini, Francesca
    Varrassi, Emilia
    Franzese, Pietro
    Ruggieri, Valeria
    Di Staso, Mario
    Marampon, Francesco
    Ferella, Letizia
    Sorce, Claudia
    Chalaszczyk, Agnieszka
    Di Cesare, Ernesto
    Tombolini, Vincenzo
    Masciocchi, Carlo
    Gravina, Giovanni Luca
    ANTICANCER RESEARCH, 2019, 39 (03) : 1609 - 1610
  • [50] Implications for tumor coverage due to the accuracy of dose calculation algorithms for 3DCRT lung radiotherapy
    Braga, D.
    Ribeiro, F.
    Carita, L.
    Zarza-Moreno, M.
    Roldao, M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S307 - S307